Bulletin
Investor Alert

New York Markets Open in:

Company Close Updates Archives | Email alerts

June 7, 2021, 5:00 p.m. EDT

Incyte Corp. stock rises Monday, outperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Incyte Corp. INCY advanced 2.14% to $85.11 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.08% to 4,226.52 and Dow Jones Industrial Average DJIA falling 0.36% to 34,630.24. This was the stock's third consecutive day of gains. Incyte Corp. closed $25.26 short of its 52-week high ($110.37), which the company achieved on July 7th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Pfizer Inc. PFE fell 0.41% to $38.99, Novartis AG ADR NVS fell 0.14% to $89.67, and Eli Lilly & Co. LLY rose 10.15% to $222.52. Trading volume (1.2 M) eclipsed its 50-day average volume of 1.1 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Incyte Corp. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.